These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6778991)

  • 1. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent pharmacokinetics of tocainide in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase.
    Elvin AT; Lalka D; Stoeckel K; du Souich P; Axelson JE; Golden LH; McLean AJ
    Clin Pharmacol Ther; 1980 Nov; 28(5):652-8. PubMed ID: 6777107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of (R,S)-tocainide. Some stereoselective aspects.
    Gal J; French TA; Zysset T; Haroldsen PE
    Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of medroxyprogesterone acetate and drug metabolism activity.
    Saarni HU; Rautio A; Kärki NT; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):251-60. PubMed ID: 6221375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
    Reddy CS; Reddy RV; Hayes AW
    J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
    Aldous CN; Chetty CS; Desaiah D
    J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of rifampin on tocainide pharmacokinetics in humans.
    Rice TL; Patterson JH; Celestin C; Foster JR; Powell JR
    Clin Pharm; 1989 Mar; 8(3):200-5. PubMed ID: 2495879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of delta 9-tetrahydrocannabinol-induced teratogenicity by stimulation and inhibition of its metabolism.
    Harbison RD; Mantilla-Plata B; Lubin DJ
    J Pharmacol Exp Ther; 1977 Aug; 202(2):455-65. PubMed ID: 886474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
    Siemann DW
    Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
    Chang TK; Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pretreatment with SKF-525A, N-Methyl-2-thioimidazole, sodium phenobarbital, or methyl cholanthrene on ethylenethiourea-induced teratogenicity in rats.
    Khera KS; Iverson F
    Teratology; 1981 Oct; 24(2):131-7. PubMed ID: 7336357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of paraldehyde to acetaldehyde by rat liver microsomes.
    Zera RT; Nagasawa HT
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):531-41. PubMed ID: 7323448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phenobarbital and SKF 525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice.
    Bus JS; Short RD; Gibson JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):749-56. PubMed ID: 4687235
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs.
    Orito K; Saito M; Fukunaga K; Matsuo E; Takikawa S; Muto M; Mishima K; Egashira N; Fujiwara M
    J Vet Pharmacol Ther; 2008 Jun; 31(3):259-64. PubMed ID: 18471148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipine.
    Hamann SR; Tan TG; Kaltenborn KE; Brouwer KL; Blouin RA; Chang SL; Vore M; McAllister RG
    Pharmacology; 1985; 30(3):121-8. PubMed ID: 3975261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition.
    Hayball PJ; Meffin PJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):631-6. PubMed ID: 3806416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.